Search - tctmd.com

Displaying 1 - 20 of 384

Sort: Relevancy | Date

News Daily News

Most Patients Struggle With Monitoring BP on Their Own

Yael L. Maxwell

January 27, 2026

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

A Little Exercise, No Matter When It’s Done, Benefits Older Women

Michael O'Riordan

October 24, 2025

News Daily News

Pregnancy-Related CV Complications on the Rise

Todd Neale

October 09, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

Advertisement

Most Patients Struggle With Monitoring BP on Their Own

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

A Little Exercise, No Matter When It’s Done, Benefits Older Women

Pregnancy-Related CV Complications on the Rise

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content